type-1

Documents about type-1

• On the cocenter of the cyclotomic Hecke algebra of type $G(r,1,n)$#152959arXiv (OAI)
• (LaCrO 3 ) m /SrCrO 3 superlattices as transparent p-type semiconductors with finite magnetization#156314HAL (France)
• Low-dose IL-2 in Established T1D - The "PROREG" Study#158123ClinicalTrials.gov
• Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion#184758ClinicalTrials.gov
• Herpes simplex virus type 1 R-loops are targets for APOBEC-mediated mutagenesis.#209542NCBI PubMed Central
• Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus#217211ClinicalTrials.gov
• Metformin Use to Improve Pregnancy Outcome in Women With Type 1 Diabetes.#272315ClinicalTrials.gov
• Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy (Italy)#279680ClinicalTrials.gov
• Cervical ataxia in Myotonic Dystrophy type 1: preliminary findings#301251IRIS
• Bottlebrush polymer conjugates for enhanced antisense oligonucleotide therapy in myotonic dystrophy type 1.#312529NCBI PubMed Central
• -Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.#332705ClinicalTrials.gov
• Dual-hormone Artificial Pancreas Versus Single-hormone Under Exercise and a Meal Challenge#346881ClinicalTrials.gov
• Telemedicine on Metabolic Control in Type 1 Diabetes Mellitus Andalusian Patients (PLATEDIAN)#356599ClinicalTrials.gov
• Body Emotional Map Method for the Reduction of Parental Stress Related to Diabetes#377358ClinicalTrials.gov
• Check It! Positive Psychology Intervention to Improve Adherence in Adolescents With T1D#377366ClinicalTrials.gov
• Integrated care for type 1 diabetes: The West Bengal model: 24-month follow-up.#382385NCBI PubMed Central
• Perceptions of adults with type 1 diabetes mellitus about diabetes management and exercise.#416129PubMed
• Automated Insulin for Management of Intrapartum Glycemia#417498ClinicalTrials.gov
• Gold and Clarke Questionnaires Identify Different People With Insulin‐Treated Diabetes and Impaired Awareness of Hypoglycaemia in Almost 60% of Cases: A Post Hoc Analysis From the Hypo‐ METRICS Study#178042HAL (France)
• Coronary Artery Disease: A Key Issue in Type 2 Myocardial Infarction: Systematic Review and Recent Findings#315008HAL (France)
• One Health Investigation into Fatal Encephalitis caused by Pigeon Paramyxovirus Type 1, France#205854HAL (France)
• Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)#216979ClinicalTrials.gov
• Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years#429684ClinicalTrials.gov
• Addressing gender and social inequities: the challenge of metabolic control in women with type 2 diabetes in Quito#147595HAL (France)
• A Rapid and Accurate PCR-Based Method for Mating-Type Determination in the Heterothallic Oomycete Plasmopara viticola , the Causal Agent of Grapevine Downy Mildew#153801HAL (France)
• Instruction Set Optimization for FM-Type Digital Signal Processor (DSP) Architectures with Integration of DVB-T2 TV Systems#222527HAL (France)
• A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.#353437ClinicalTrials.gov
• Role of Pentraxin-3 in Assessment of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus#427409HAL (France)
• A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects#143765ClinicalTrials.gov
• The Effects of Antecedent Hypoglycemia or Exercise on the Response of the Brain to Subsequent Hypoglycemia#146356ClinicalTrials.gov
• Cheeky Cheating or a Sensible Strategy? ‘Sweep Parameters’ in Bucket‐Type Hydrological Models#156296HAL (France)
• Toward Personalized Medicine in Type 1 Diabetes: Understanding How Patient Heterogeneity Influences Therapeutic Efficacy.#159780NCBI PubMed Central
• Gingival Crevicular IL-34 and CSF-1 Levels in Patients With Periodontitis and Uncontrolled Type 2 Diabetes#217197ClinicalTrials.gov
• Effect of CGM With Predictive Alarm on Hypoglycemia in Young Patients With T1D.#230340ClinicalTrials.gov
• Variability in the TLR3 type I interferon pathway is predictive of RNA vaccine responses#235346HAL (France)
• Comparison of Two Management Systems in Patients With Type 1 Diabetes (Pediatric SmartHome)#257059ClinicalTrials.gov
• Measurement of Glucose/Glycogen Metabolism in Humans Using Magnetic Resonance at 4 or 7 Tesla#267956ClinicalTrials.gov
• A Phase 1 Study of Ertugliflozin in Healthy Male Participants (MK-8835-020)#290923ClinicalTrials.gov
• A stronger type I interferon signature distinguishes ANCA-associated vasculitis phenotypes and predicts kidney prognosis#291821HAL (France)
• Leucocyte adhesion deficiency type 1 with developmental delay secondary to CMV infection and filiation questions#292972Repositorio USS
• A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily Injections#300407ClinicalTrials.gov
• Unraveling the structural features of Dion–Jacobson-type layered perovskite-related material HCa2Nb3O10·1.5H2O#305562OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Metformin Plus Insulin on Non-obese Autoimmune Diabetes#343811ClinicalTrials.gov
• Continuous Glucose Monitoring Initiation at Hospital Discharge#424334ClinicalTrials.gov
• The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM#424338ClinicalTrials.gov
• Toward Personalized Decision Support Systems for Type 1 Diabetes: Integrating Psychobehavioral Factors and Glycemic Control.#425083NCBI PubMed Central
• Efeitos de instruções e de feedback sobre adesão ao tratamento em adolescentes com diabetes tipo 1#416493RIUFPA
• Glycemic Variability Bridges Time in Range and Time in Tight Range: A Unified Equation for Both Type 1 and Type 2 Diabetes Based on Large-Scale Continuous Glucose Monitoring Data.#159797NCBI PubMed Central
• Systèmes photo-amorceurs de type I utilisables dans la photopolymérisation induite par LED et l'impression 3D, et leur cytotoxicité#254263HAL (France)
• Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment#146404ClinicalTrials.gov